ADAR1 Capital Management’s Akero Therapeutics AKRO Stock Holding History

ADAR1 Capital Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22,500	Closed	-$626K	–	205
2024 Q4	$626K	Hold	22,500	–	–	0.13%	104
2024 Q3	$646K	Buy	+22,500	New	+$587K	0.11%	102

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADAR1 Capital Management's AKRO Position: Q4 2025 in Review

ADAR1 Capital Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 6,143 shares — an estimated $292K sold.

ADAR1 Capital Management first reported a position in AKRO in Q4 2023 and held it in 8 quarters. The position peaked at $2.88M in Q1 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

ADAR1 Capital Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
ADAR1 Capital Management sold 6,143 Akero Therapeutics shares in Q4 2025, an estimated $292K.
ADAR1 Capital Management first reported a position in Akero Therapeutics in Q4 2023 and held it in 8 quarters.
ADAR1 Capital Management's Akero Therapeutics position peaked at $2.88M in Q1 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on ADAR1 Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.